Sectoral Asset Management’s Acadia Pharmaceuticals ACAD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Sell |
-15,060
| Closed | -$472K | – | 93 |
|
|
2023
Q4 | $472K | Sell |
15,060
-194,900
| -93% | -$6.1M | 0.2% | 80 |
|
|
2023
Q3 | $4.38M | Buy |
+209,960
| New | +$4.38M | 0.85% | 51 |
|
|
2021
Q1 | – | Sell |
-654,414
| Closed | -$35M | – | 114 |
|
|
2020
Q4 | $35M | Buy |
654,414
+97,900
| +18% | +$5.23M | 2.47% | 11 |
|
|
2020
Q3 | $23M | Buy |
556,514
+213,851
| +62% | +$8.82M | 1.97% | 16 |
|
|
2020
Q2 | $16.6M | Buy |
342,663
+105,213
| +44% | +$5.1M | 1.52% | 24 |
|
|
2020
Q1 | $10M | Buy |
237,450
+93,000
| +64% | +$3.93M | 1.93% | 18 |
|
|
2019
Q4 | $6.18M | Buy |
+144,450
| New | +$6.18M | 0.92% | 44 |
|
|
2018
Q2 | – | Sell |
-783,424
| Closed | -$17.6M | – | 68 |
|
|
2018
Q1 | $17.6M | Sell |
783,424
-348,298
| -31% | -$7.83M | 1.93% | 20 |
|
|
2017
Q4 | $34.1M | Buy |
1,131,722
+309,330
| +38% | +$9.31M | 4.26% | 3 |
|
|
2017
Q3 | $31M | Sell |
822,392
-276,417
| -25% | -$10.4M | 3.99% | 4 |
|
|
2017
Q2 | $30.6M | Buy |
1,098,809
+427,696
| +64% | +$11.9M | 3.35% | 9 |
|
|
2017
Q1 | $23.1M | Sell |
671,113
-505,430
| -43% | -$17.4M | 2.69% | 18 |
|
|
2016
Q4 | $33.9M | Buy |
1,176,543
+1,120,646
| +2,005% | +$32.3M | 3.76% | 6 |
|
|
2016
Q3 | $1.78M | Buy |
55,897
+26,315
| +89% | +$837K | 0.17% | 52 |
|
|
2016
Q2 | $960K | Sell |
29,582
-661,118
| -96% | -$21.5M | 0.1% | 60 |
|
|
2016
Q1 | $19.3M | Buy |
+690,700
| New | +$19.3M | 0.93% | 31 |
|